Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEEEK
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,282
Award facts
- Contract value 100% obligated
- $10,282.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,282.37 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order was issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to supply pharmaceutical products to Department of Defense healthcare facilities worldwide. The delivery order carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. No subcontractors are identified in the award documentation.
DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products and medical consumables, including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals such as oncology treatments, immunosuppressants, and emergency medications. The parent IDC contract, designated SPE2DR and awarded on November 13, 2025, has a $499,999,999 ceiling value with an ultimate completion date of December 31, 2036, structured as a 30-month base period with three 30-month option periods. This delivery order, due for completion by December 11, 2025, represents one of numerous orders the company has fulfilled for the Defense Logistics Agency's Medical Supply Chain division, underscoring its critical role as a pharmaceutical supplier for military healthcare operations.
Quick answers
Who was awarded contract SPE2DU26FEEEK?
SPE2DU26FEEEK was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DU26FEEEK worth?
The government has obligated $10,282 on SPE2DU26FEEEK.
Is contract SPE2DU26FEEEK an order under another contract?
Yes. SPE2DU26FEEEK is a delivery order under SPE2DU25D9439, an indefinite delivery contract.
Was contract SPE2DU26FEEEK competed?
The extent of competition for SPE2DU26FEEEK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award